Mounjaro and a Fast Heart Rate: What You Should Know

What the tirzepatide trial data actually recorded

The SURMOUNT-1 study (a 72-week phase 3 trial involving 2,539 adults with obesity) reported modest increases in resting heart rate across the tirzepatide dose groups compared with placebo, a finding consistent across the broader SURMOUNT programme and reflected in the medicine's approved summary of product characteristics on the eMC. The average rise was small in absolute terms, but the clinical picture across thousands of participants was consistent enough that a raised heart rate appears as a listed side effect in the official patient information leaflet.

GLP-1 receptor agonists as a class are associated with this effect, and tirzepatide's dual action on both GIP and GLP-1 receptors doesn't appear to amplify it meaningfully beyond what is seen with single-pathway agents. The mechanism isn't fully resolved, but it is thought to relate in part to the autonomic nervous system responding to changes in gut motility and caloric intake. What matters practically is that the increase is usually small, and for most people it doesn't cause symptoms at all. The ones who do notice it most often describe a slightly elevated or fluttery feeling in the first few days after a new pen begins.

For anyone wanting to read further into how Mounjaro affects heart rate, the tirzepatide and heart rate overview goes into the mechanism in more detail.

When a fast heart rate on Mounjaro is expected, and when it isn't

There is a difference between a mildly elevated resting rate that settles within a week or two and a heart rate that is persistently fast, irregular, or accompanied by other symptoms. The NHS tirzepatide medicine page lists increased heart rate among the side effects that are generally worth mentioning to a healthcare professional but do not usually require emergency action, alongside the more familiar gastrointestinal effects such as nausea or indigestion.

What does warrant prompt attention: a heart rate that stays consistently above 100 beats per minute at rest; a rhythm that feels irregular or fluttering rather than just fast; palpitations accompanied by chest tightness, breathlessness, dizziness, or near-fainting. These aren't necessarily caused by Mounjaro (plenty of things raise heart rate) but they need to be assessed. Don't attempt to manage them by adjusting your dose yourself; that decision belongs with your prescriber.

It's also worth remembering that dehydration, which can occur if GI side effects like vomiting or diarrhoea are pronounced, raises heart rate independently. Staying adequately hydrated matters more than people sometimes realise on GLP-1 treatment.

Our guide to a high heart rate on Mounjaro covers the practical steps if your rate is consistently elevated.

How this fits with Mounjaro's cardiovascular safety record

The modest rise in resting heart rate sits alongside a broader cardiovascular picture that is, overall, reassuring. The SURMOUNT trial programme did not identify a significant increase in major adverse cardiovascular events associated with tirzepatide. NICE's appraisal of tirzepatide for weight management, published as TA1026, considered the full evidence base and recommended the medicine for eligible adults, a judgement that weighs potential harms alongside demonstrated benefits.

That said, anyone with a pre-existing heart rhythm condition (such as atrial fibrillation or supraventricular tachycardia) should discuss Mounjaro with their prescriber before starting, and should flag any change in their cardiac symptoms promptly if they are already on treatment. The prescriber reviewing your consultation at nume takes a full medical history precisely because that context changes the picture.

Questions about alcohol and heart rate on Mounjaro come up too, since alcohol raises resting rate on its own. The page on drinking on Mounjaro covers what is currently understood there. For a broader look at the evidence around Mounjaro and the heart, the Mounjaro and heart health page is the place to start.

What to do if you're noticing a fast heart rate, and how to raise it

If you've started Mounjaro or recently moved to a higher dose and you're noticing your heart feels faster than usual, the most useful first step is to check: is it fast at rest or only during activity? Is it regular or irregular? Does it settle, or is it persistent? Keeping a brief note for a few days helps (including your resting rate first thing in the morning) so you have something concrete to share with a clinician.

Contact your GP or call 111 if you're worried or the rate is high and sustained. For anything severe (chest pain, difficulty breathing, collapse) call 999. If your concern is specifically about how Mounjaro may be contributing, your prescriber at a regulated pharmacy can review your situation and adjust the treatment plan if needed. You can report suspected side effects to the MHRA directly at yellowcard.mhra.gov.uk, that feedback genuinely shapes how regulators monitor medicines in the real world.

Mounjaro is a prescription-only medicine and every supply through nume involves a clinical review before dispatch. If you are on treatment and your symptoms are changing, getting an answer through your aftercare channel is faster than starting from scratch. For those still exploring whether tirzepatide might be right for them, the free consultation is where a prescriber reviews your full picture. The cost of Mounjaro page explains what is included in the price if that's helpful context.